|
Cadenas-Garrido P, Garcia-Serna AM, Parrado A, Martinez-Garcia J, Herrera-Suarez M, Canovas M, de Diego Puente T, Saceda M, Pelegrin P, Diaz-Carrasco MS, Martin-Orozco E. Acquisition of drug-resistance induces cytokine reprogramming in a human leukemic cell line. Role of p38 MAPK. Cell Commun Signal. 2026 Jan 29. doi: 10.1186/s12964-026-02653-1. Online ahead of print. PubMed PMID: 41612452.
AÑO: 2026; IF: 11.6
|
41612452
|
García-Villalba J., Hurtado-Navarro L., Angosto-Bazarra D., Baroja-Mazo A., Pelegrin P. The Open Reading Frame 7b of the SARS-CoV-2 Disperse Trans-Golgi and Activate the NLRP3 Inflammasome. Journal of Medical Virology. April 2026. 98. 10.1002/jmv.70894
AÑO: 2026; IF: 3.7
|
|
Gorecki D.C., Adinolfi E., Adriouch S., Coutinho-Silva R., Engel T., Gölöncsér F., Haag F., Illes P., Jacobson K.A., Koch-Nolte F., Mansoor S.E., Matute C., Melino G., Novak I., Pegoraro A., Pelegrin P., Piacentini M., Robson S.C., Rumney R.M.H., Seman M., Sluyter R., Sperlagh B., Tang Y., Tarantini M., Ulrich H., Vouret-Craviari V., Ye Q., Yegutkin G.G., Verkhratsky A. Methodological guidelines for P2X receptor assays and data interpretation. Cell Death and Disease. December 2026. 17. 10.1038/s41419-026-08730-0
AÑO: 2026; IF: 12.2
|
|
Schachter J, Guijarro A, Angosto-Bazarra D, Pinilla M, Hurtado-Navarro L, Meunier E, Perez-Oliva AB, Schwarzbaum PJ, Pelegrin P. Gasdermin D mediates a fast transient release of ATP after NLRP3 inflammasome activation before ninjurin 1-induced lytic cell death. Cell Rep. 2025 Feb 25;44(2):115233. doi: 10.1016/j.celrep.2025.115233. Epub 2025 Feb 1. PubMed PMID: 40010300.
AÑO: 2025; IF: 7.7
|
|
Pizzuto M., Monteleone M., Burgener S.S., Began J., Kurera M., Chia J.R., Frampton E., Crawford J., Oliveira M., Kenney K.M., Coombs J.R., Yamamoto M., Man S.M., Broz P., Pelegrin P., Schroder K. Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4/11. EMBO Journal. 18 August 2025. 44:4419-4442. 10.1038/s44318-025-00507-z
AÑO: 2025; IF: 8.4
|